Soft Tissue Repair Market Growth Forecast Outlook Mar-2017

Global Soft Tissue Repair Market 2017-2021
The Soft Tissue Repair market report contains a comprehensive market and vendor landscape in
addition to a SWOT analysis of the key vendors for 2017-2021. The following companies are the key
players in the global soft tissue repair market: Acelity, Arthrex, Ethicon, and Medtronic.
Other Prominent Vendors in the market are ACE Surgical Supply, AlloCure, AlloSource, Anterogen,
Antibe Therapeutics, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Biogen,
BioRestorative Therapies, Biostage, BioTissue Technologies, BrainStorm Cell Therapeutics, Caladrius
Biosciences, Celgene, Cell Therapy, CONMED, CRC for Cell Therapy Manufacturing, Fibrocell Science,
Healthpoint, Histogen, Holostem Terapie Avanzate, Integra Life Sciences, ISTO Technologies, Janssen
Pharmaceutical, K2M, Mesoblast, NeoStem etc.
For More Information Inquire @
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=929119
Market Trend
One trend in soft tissue repair market increasing strategic alliances. Major vendors are entering strategic
alliances with other vendors for drug development and manufacturing. This trend is anticipated during
the forecast period. Leading vendors in the market are undertaking M&A to strengthen their global
position and to improve their commercial capabilities. Through increasing strategic alliances, many
companies are receiving upfront and royalty payment, which encourages many small companies to
involve into R&D and develop novel soft tissue repair products.
Market Driver
According to the report, one driver in soft tissue repair market is rise in strategic partnerships for
distribution of products. Vendors form strategic partnerships to expand their businesses, extend their
product offerings, and increase their market shares. These partnerships also help companies to align
their technologies with each other's innovative medical device portfolio. Through distribution
partnerships, the small companies are expanding their presence in various geographical regions. This
will help them to increase their market share globally, which will also provide intense competition to
large vendors.
Market Challenge
One challenge in soft tissue repair market is high cost of clinical trials and failure rate in clinical trials.
Most vendors conduct clinical trials in developed countries such as the US, the UK, Germany, France,
Japan, Singapore, and South Korea. As these are high-income countries, the cost of clinical trials and
product launch in these countries will be high. Most of the small vendors or start-up biotech companies
seek government or private funding, but most of the organizations provide limited amount of funding or
grant to vendors if the targeted goal is completed. Estimated cost of soft tissue repair product such as
cell therapy-based products from pre-clinical developmental stage to approval of product can cost up to
$1.5 billion to the company.
Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=929119